Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of gamma-secretase activity
Alzheimer Amyloid Peptide A beta(42) Regulates Gene Expression of Transcription and Growth Factors
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-beta Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Alzheimer's disease: addressing a twenty-first century plague
Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject
Alzheimer's disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch-Nyhan disease)
Alzheimer's disease patients institutionalized in group homes run by long-term care insurance exhibit fewer symptoms of behavioural problems as evaluated by the Behavioural Pathology in Alzheimer's Disease Rating Scale
Alzheimer's Disease: A Financial Crisis and the Commonwealth of Pennsylvania
Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes
Alzheimer's Protective A2T Mutation Changes the Conformational Landscape of the A beta(1-42) Monomer Differently Than Does the A2V Mutation
Alzheimer's disease - Recent biomarker developments in relation to updated diagnostic criteria
Alzheimer dementia with sparse amyloid-AD mimic or variant?
Alzheimer's disease: the amyloid hypothesis and the Inverse Warburg effect
Alzheimer's disease update
Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model
Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degus
Alzheimer's Disease and the Elderly in Israel: Are We Paying Enough Attention to the Topic in the Arab Population?
Alzheimer's disease: Unique markers for diagnosis & new treatment modalities
Alzheimer's disease-causing proline substitutions lead to presenilin 1 aggregation and malfunction
Alzheimer's in 3D culture: Challenges and perspectives
Alzheimer's Disease: Lessons Learned from Amyloidocentric Clinical Trials
Alzheimer's disease and its treatment costs: case study in the Czech Republic
Alzheimer's 100th anniversary of death and his contribution to a better understanding of Senile dementia
Alzheimer's disease: Potential preventive, non-invasive, intervention strategies in lowering the risk of cognitive decline - A review study
Alzheimer's disease-related amyloid-beta induces synaptotoxicity in human iPS cell-derived neurons
Alzheimer's Disease: Mechanism and Approach to Cell Therapy
Alzheimer's disease detection in functional images using 2D Gabor wavelet analysis
Alzheimer's Disease Patients Generate Late and Reduced Cortical Activity For Movement Preparation
Alzheimer's disease in United Kingdom
Alzheimer's disease: clinical trials and drug development
Alzheimer's Disease and Retinal Neurodegeneration
Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical characterization
Alzheimer's disease: More than amyloid
Alzheimer's Disease REPLY
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans
Alzheimer's disease neuropathologic changes in semantic dementia
Alzheimer's Disease and Down Syndrome Rodent Models Exhibit Audiogenic Seizures
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning
Alzheimer's and related diseases Toward earlier and more accurate diagnosis
Alzheimer's Disease - A Scientometric Analysis and Data Acquisition
Alzheimer Disease: Functional Abnormalities in the Dorsal Visual Pathway
Alzheimer's disease: brain expression of a metabolic disorder?
Alzheimer's disease and endothelial dysfunction
Alzheimer and Perusini: Patient RM and his kindred 1773-2009
Alzheimer's disease and hearing loss
Alzheimer's disease: Report of two autopsy cases with a clinical diagnosis of corticobasal degeneration
Alzheimer's disease: immunity and diagnosis
Alzheimer's Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible
Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2
Alzheimer's Disease Modifies Progenitor Cell Expression of Monoamine Oxidase B in the Subventricular Zone
Alzheimer's disease (AD) and executive dysfunction. A case-control study on the significance of frontal white matter changes detected by diffusion tensor imaging (DTI)
Alzheimer's Disease: The Quest to Understand Complexity
Alzheimer's disease, Parkinson's disease and essential tremor: three common degenerative diseases with shared mechanisms?
Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?
Alzheimer's Disease Amyloid-beta Links Lens and Brain Pathology in Down Syndrome
Alzheimer's-related endosome dysfunction in Down syndrome is A beta-independent but requires APP and is reversed by BACE-1 inhibition
Alzheimer's Disease-Linked Presenilin Mutation (PS1M146L) Induces Filamin Expression and gamma-Secretase Independent Redistribution
Alzheimer disease identification using amyloid imaging and reserve variables Proof of concept
Alzheimer's secretases regulate voltage-gated sodium channels
Alzheimer A beta Peptide Induces Chromosome Mis-Segregation and Aneuploidy, Including Trisomy 21: Requirement for Tau and APP
Alzheimer A beta(1-42) Monomer Adsorbed on the Self-Assembled Monolayers
Alzheimer disease prevention: Focus on cardiovascular risk, not amyloid?
Alzheimer's A beta Peptides with Disease-Associated N-Terminal Modifications: Influence of Isomerisation, Truncation and Mutation on Cu2+ Coordination
Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2
Alzheimer's Disease: The Pros and Cons of Pharmaceutical, Nutritional, Botanical, and Stimulatory Therapies, with a Discussion of Treatment Strategies from the Perspective of Patients and Practitioners
Alzheimer Disease
Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization
Alzheimer's disease: Cerebral glaucoma?
Alzheimer's Disease Amyloid beta-Protein and Synaptic Function
Alzheimer's disease influence on the perception of quality of life from the elderly people
Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
Alzheimer's disease amyloid-beta peptide analogue alters the ps-dynamics of phospholipid membranes
Alzheimer's Disease: SPECT and PET Tracers for Beta-Amyloid Imaging
Alzheimer%26apos;s disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
Alzheimer Disease and Behavioral Variant Frontotemporal Dementia: Automatic Classification Based on Cortical Atrophy for Single-Subject Diagnosis
Alzheimer's disease: are blood and brain markers related? A systematic review
Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss
Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities
Alzheimer's disease: An acquired neurodegenerative laminopathy
Alzheimer's disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities
Alzheimer disease: modeling an A beta-centered biological network
Alzheimer%26apos;s and Parkinson%26apos;s Diseases: Expected Economic Impact on Europe-A Call for a Uniform European Strategy
Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior